Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape

Ali Kermanizadeh,1,2 Leagh G Powell,1 Vicki Stone,1 Peter Møller2 1NanoSafety Research Group, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh, UK; 2Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kermanizadeh A, Powell LG, Stone V, Møller P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/23450899ddbe4f67bd39811302397d06
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:23450899ddbe4f67bd39811302397d06
record_format dspace
spelling oai:doaj.org-article:23450899ddbe4f67bd39811302397d062021-12-02T07:57:32ZNanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape1178-2013https://doaj.org/article/23450899ddbe4f67bd39811302397d062018-11-01T00:00:00Zhttps://www.dovepress.com/nanodelivery-systems-and-stabilized-solid-drug-nanoparticles-for-orall-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Ali Kermanizadeh,1,2 Leagh G Powell,1 Vicki Stone,1 Peter Møller2 1NanoSafety Research Group, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh, UK; 2Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark Abstract: The use of nanoparticles as a means of targeted delivery of therapeutics and imaging agents could greatly enhance the transport of biologically active contents to specific target tissues, while avoiding or reducing potentially undesired side effects. Generally speaking, the oral route of administration is associated with good patient compliance, as it is convenient, economical, noninvasive, and does not require special training. Here, we review the progress of the utilization of nanodelivery-system carriers or stabilized solid-drug nanoparticles following oral administration, with particular attention on toxicological data. Mechanisms of cytotoxicity are discussed and the problem of extrapolating knowledge to human scenarios highlighted. Additionally, issues associated with administration of drugs via the oral route are underlined, while strategies utilized to overcome these are highlighted. This review aims to offer a balanced overview of strategies currently being used in the application of nanosize constructs for oral medical applications. Keywords: nanomedicine, oral route of delivery, nanomaterials, nano-stabilized solid drugsKermanizadeh APowell LGStone VMøller PDove Medical PressarticleNanomedicineoral route of exposurenanomaterialstoxicityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 7575-7605 (2018)
institution DOAJ
collection DOAJ
language EN
topic Nanomedicine
oral route of exposure
nanomaterials
toxicity
Medicine (General)
R5-920
spellingShingle Nanomedicine
oral route of exposure
nanomaterials
toxicity
Medicine (General)
R5-920
Kermanizadeh A
Powell LG
Stone V
Møller P
Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
description Ali Kermanizadeh,1,2 Leagh G Powell,1 Vicki Stone,1 Peter Møller2 1NanoSafety Research Group, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh, UK; 2Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark Abstract: The use of nanoparticles as a means of targeted delivery of therapeutics and imaging agents could greatly enhance the transport of biologically active contents to specific target tissues, while avoiding or reducing potentially undesired side effects. Generally speaking, the oral route of administration is associated with good patient compliance, as it is convenient, economical, noninvasive, and does not require special training. Here, we review the progress of the utilization of nanodelivery-system carriers or stabilized solid-drug nanoparticles following oral administration, with particular attention on toxicological data. Mechanisms of cytotoxicity are discussed and the problem of extrapolating knowledge to human scenarios highlighted. Additionally, issues associated with administration of drugs via the oral route are underlined, while strategies utilized to overcome these are highlighted. This review aims to offer a balanced overview of strategies currently being used in the application of nanosize constructs for oral medical applications. Keywords: nanomedicine, oral route of delivery, nanomaterials, nano-stabilized solid drugs
format article
author Kermanizadeh A
Powell LG
Stone V
Møller P
author_facet Kermanizadeh A
Powell LG
Stone V
Møller P
author_sort Kermanizadeh A
title Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
title_short Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
title_full Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
title_fullStr Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
title_full_unstemmed Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
title_sort nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/23450899ddbe4f67bd39811302397d06
work_keys_str_mv AT kermanizadeha nanodeliverysystemsandstabilizedsoliddrugnanoparticlesfororallyadministeredmedicinecurrentlandscape
AT powelllg nanodeliverysystemsandstabilizedsoliddrugnanoparticlesfororallyadministeredmedicinecurrentlandscape
AT stonev nanodeliverysystemsandstabilizedsoliddrugnanoparticlesfororallyadministeredmedicinecurrentlandscape
AT møllerp nanodeliverysystemsandstabilizedsoliddrugnanoparticlesfororallyadministeredmedicinecurrentlandscape
_version_ 1718399028962525184